Petros Pharmaceuticals SG&A Expense (Annual) Analysis

Petros Pharmaceuticals Inc (PTPI)

0.402 -0.01 (-3.13%) USD | NASDAQ | Jul 08, 16:00

0.402 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Annual) Chart

Historical SG&A Expense (Annual) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	9.262M
December 31, 2022	12.21M
December 31, 2021	15.59M

Date	Value
December 31, 2020	15.68M
December 31, 2019	19.73M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Annual) Range, Past 5 Years

9.262M

Minimum

2023

19.73M

Maximum

2019

14.49M

Average

15.59M

Median

2021

SG&A Expense (Annual) Benchmarks